Report error Found 224 with Last Name = 'lin' and Initial = 'yw'
Affinity DataIC50: 0.423nMAssay Description:Inhibition of recombinant JAK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assayMore data for this Ligand-Target Pair
Ligand InfoSimilars
Affinity DataIC50: 0.700nMAssay Description:Inhibition of N-terminal His-tagged catalytic domain human JAK3 (795 to 1124 residues) expressed in Sf21 insect cells using Biotin-Lyn-Substrate-2 as...More data for this Ligand-Target Pair
Ligand InfoSimilars
Ligand Info
Ligand Info
Affinity DataIC50: 1.60nMAssay Description:Inhibition of recombinant JAK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assayMore data for this Ligand-Target Pair
Ligand InfoSimilars
Ligand Info
Ligand Info
Ligand Info
Ligand Info
Ligand Info
Ligand Info
Affinity DataIC50: 2.60nMAssay Description:Inhibition of recombinant JAK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assayMore data for this Ligand-Target Pair
Ligand InfoSimilars
Affinity DataIC50: 2.70nMAssay Description:Inhibition of recombinant JAK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assayMore data for this Ligand-Target Pair
Ligand InfoSimilars
Affinity DataIC50: 2.80nMAssay Description:Inhibition of JAK2 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 3.30nMAssay Description:Inhibition of JAK1 (unknown origin)More data for this Ligand-Target Pair
Ligand Info
Ligand Info
Affinity DataIC50: 3.80nMAssay Description:Inhibition of recombinant JAK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assayMore data for this Ligand-Target Pair
Ligand InfoSimilars
Affinity DataIC50: 3.80nMAssay Description:Inhibition of recombinant JAK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assayMore data for this Ligand-Target Pair
Ligand InfoSimilars
Affinity DataIC50: 3.90nMAssay Description:Inhibition of N-terminal GST tagged catalytic domain human JAK1 (850 to 1154 end residues) expressed in Sf21 insect cells using Biotin-Lyn-Substrate-...More data for this Ligand-Target Pair
Ligand InfoSimilars
Ligand Info
Affinity DataIC50: 4.60nMAssay Description:Inhibition of recombinant JAK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assayMore data for this Ligand-Target Pair
Ligand InfoSimilars
Affinity DataIC50: 4.80nMAssay Description:Inhibition of N-terminal GST tagged catalytic domain human TYK2 (871 to 1187 end residues) expressed in Sf21 insect cells using Biotin-IRS1-Substrate...More data for this Ligand-Target Pair
Ligand InfoSimilars
Affinity DataIC50: 5nMAssay Description:Inhibition of N-terminal His-tagged catalytic domain human JAK2 (826 to 1132 end residues) expressed in Sf21 insect cells using Biotin-Lyn-Substrate-...More data for this Ligand-Target Pair
Ligand InfoSimilars
Ligand Info
Ligand Info
Affinity DataIC50: 5.70nMAssay Description:Inhibition of recombinant epitope tagged JAK2 (unknown origin) (828 to 1132 residues) using peptide substrate in presence of ATP by time-resolved flu...More data for this Ligand-Target Pair
Affinity DataIC50: 5.80nMAssay Description:Inhibition of recombinant epitope tagged JAK1 (unknown origin) (837 to 1142 residues) using peptide substrate in presence of ATP by time-resolved flu...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 6.90nMAssay Description:Inhibition of recombinant JAK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assayMore data for this Ligand-Target Pair
Ligand InfoSimilars
Ligand Info
Ligand Info
Ligand Info
Affinity DataIC50: 9.60nMAssay Description:Inhibition of recombinant JAK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assayMore data for this Ligand-Target Pair
Ligand InfoSimilars
Ligand Info
Ligand Info
Ligand Info
















3D Structure (crystal)
















